Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-13

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Accord Healthcare's mycophenolate mofetil, a generic immunosuppressant, to support its use in preventing organ t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)